Opko Health acquires Israel-based medical device company, Inspiro Medical
Inspiro is developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists to treat respiratory diseases.
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.